竹笋娅娅
Lv4
790 积分
2021-06-29 加入
-
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
1个月前
已完结
-
Irinotecan-based regimens for recurrent glioblastoma multiforme: [corrected] a systematic review
2个月前
已关闭
-
PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data
2个月前
已完结
-
Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): results from a phase II basket trial
3个月前
已关闭
-
Propensity Score Matching: A Statistical Method
3个月前
已完结
-
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
-
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial
3个月前
已完结
-
Head and neck cancer: Current challenges and future perspectives
4个月前
已完结
-
Lithium response in bipolar disorder: Genetics, genomics, and beyond
4个月前
已完结
-
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
5个月前
已完结